STRC Sarcos Technology & RoboticsWatchlist
About Sarcos Technology & Robotics Company
Sarcos Technology and Robotics Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. It also provides software solutions that enable task autonomy. Its mobile robotic systems include the Guardian S, Guardian GT, Guardian XO, and Guardian XT. The company was founded in 2015 and is headquartered in Salt Lake City, UT.
Sarcos Technology Q3 2023 Adj EPS $(0.66) Misses $(0.59) Estimate, Sales $1.83M Beat $1.20M Estimate
Sarcos Technology (NASDAQ:STRC) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.59) by 11.86 percent. This is a 8.33 percent increase over losses of $
Recap: Sarcos Technology Q3 Earnings
Sarcos Technology (NASDAQ:STRC) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM.Here's what investors need to know about the announcement.EarningsSarcos Technology missed es
Sarcos Pivots to Robotics AI Software Platform; Cuts Workforce by 150 Employees
Oh no, you liars and losers. Scrapping the coolest robot without delivery.
AI would make some recovery of stock prices. Potentially to 6 to 10 dollar level. But for people who bought 60 (recal reverse split), disaster including me.
Although company swears to be civilian purpose, this a perfect platform for power armor, that a single soldier can have sufficient ammor against guns and frags, perform as IFV. The technology would eventually lead to mobile suits.
$Jin Medical International(ZJYL.US)$
$Alpine Summit Energy Partners(ALPS.US)$
These stocks reverse split at new lows and shorts will have to cover soon sending them way up. $Talis Biomedical(TLIS.US)$ and $Sarcos Technology & Robotics(STRC.US)$
Good progress. Hope you can deliver! Then buy a lot for investment! Best betting time is Summer 2023 when they deliver, and clients can really use the robot.
Sarcos began initial production of commercial units of its Sapien 6M robotic systems ahead of schedule during the third quarter and continues to expect to commence initial production of commercial units of the Guardian XT teleoperated robotic system by the end of 2022, in both cases to b...
• $Plantronics(POLY.US)$ +50% (to be acquired by HP Inc ($HP Inc(HPQ.US)$) for $40.00 per share)
• $Axsome Therapeutics(AXSM.US)$ +21.6% (Jazz Pharma divests Sunosi to Axsome Therapeutics)
• $Staar Surgical(STAA.US)$ +15.4% (receives FDA approval of EVO Visian Implantable Collamer Lenses)
• $Sarcos Technology & Robotics(STRC.US)$ +7.6% (announces that the Company has reached a definitive merger agreement to acquire Pittsburgh-base...